Lars Riedemann

2.8k total citations
10 papers, 723 citations indexed

About

Lars Riedemann is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lars Riedemann has authored 10 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Lars Riedemann's work include Glioma Diagnosis and Treatment (4 papers), Brain Metastases and Treatment (3 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Lars Riedemann is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Brain Metastases and Treatment (3 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Lars Riedemann collaborates with scholars based in Germany, United States and Belgium. Lars Riedemann's co-authors include Rakesh K. Jain, Frank Winkler, Thomas Schmidt, Géza Schermann, Gergely Solecki, Laura Castro, Iván M. Moya, Aı̈da Valls, Xiaohong Wang and Carmen Ruiz de Almodóvar and has published in prestigious journals such as Developmental Cell, International Journal of Radiation Oncology*Biology*Physics and Molecular Cancer Therapeutics.

In The Last Decade

Lars Riedemann

10 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Riedemann Germany	9	292	199	140	122	120	10	723
Britt Johnson United States	17	451 1.5×	75 0.4×	73 0.5×	133 1.1×	45 0.4×	40	1.0k
Isabelle Thiffault United States	23	822 2.8×	88 0.4×	48 0.3×	108 0.9×	97 0.8×	65	1.4k
Marja Hietala Finland	17	485 1.7×	107 0.5×	73 0.5×	39 0.3×	38 0.3×	37	918
Itay Chowers Israel	20	862 3.0×	94 0.5×	93 0.7×	123 1.0×	56 0.5×	87	1.5k
Kristin D. Kernohan Canada	18	887 3.0×	91 0.5×	56 0.4×	46 0.4×	80 0.7×	49	1.3k
Xueqiu Jian United States	11	940 3.2×	58 0.3×	75 0.5×	50 0.4×	60 0.5×	17	1.5k
Saman Sizdahkhani United States	9	208 0.7×	38 0.2×	124 0.9×	67 0.5×	126 1.1×	30	613
Taila Hartley Canada	20	591 2.0×	59 0.3×	29 0.2×	41 0.3×	77 0.6×	54	1.2k
Hester Y. Kroes Netherlands	19	973 3.3×	121 0.6×	45 0.3×	23 0.2×	40 0.3×	38	1.5k
Yi‐Hsien Chen Taiwan	16	309 1.1×	33 0.2×	90 0.6×	78 0.6×	124 1.0×	51	705

Countries citing papers authored by Lars Riedemann

Since Specialization

Citations

This map shows the geographic impact of Lars Riedemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Riedemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Riedemann more than expected).

Fields of papers citing papers by Lars Riedemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Riedemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Riedemann. The network helps show where Lars Riedemann may publish in the future.

Co-authorship network of co-authors of Lars Riedemann

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Riedemann. A scholar is included among the top collaborators of Lars Riedemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Riedemann. Lars Riedemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Riedemann, Lars, et al.. (2024). The path forward for large language models in medicine is open. npj Digital Medicine. 7(1). 339–339. 13 indexed citations

Stern, Ariel Dora, Jörg F. Debatin, Julia Hagen, et al.. (2022). Advancing digital health applications: priorities for innovation in real-world evidence generation. The Lancet Digital Health. 4(3). e200–e206. 83 indexed citations

Burth, Sina, Dorothea Kronsteiner, Meinhard Kieser, et al.. (2021). Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?. Journal of Neuro-Oncology. 152(3). 483–490. 15 indexed citations

Berghoff, Anna S., Michael O. Breckwoldt, Lars Riedemann, et al.. (2020). Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases. Neuro-Oncology Advances. 2(1). vdaa038–vdaa038. 21 indexed citations

Berberich, Anne, Thomas Hielscher, Philipp Kickingereder, et al.. (2018). Nonmeasurable Speckled Contrast-Enhancing Lesions Appearing During Course of Disease Are Associated With IDH Mutation in High-Grade Astrocytoma Patients. International Journal of Radiation Oncology*Biology*Physics. 102(5). 1472–1480. 1 indexed citations

Wang, Xiaohong, Aı̈da Valls, Géza Schermann, et al.. (2017). YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis. Developmental Cell. 42(5). 462–478.e7. 273 indexed citations

Batista, Ana, Lars Riedemann, Trupti D. Vardam, & Rakesh K. Jain. (2015). Targeting the Tumor Microenvironment to Enhance Pediatric Brain Cancer Treatment. The Cancer Journal. 21(4). 307–313. 14 indexed citations

Lu‐Emerson, Christine, Matija Snuderl, Nathaniel D. Kirkpatrick, et al.. (2013). Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma. Neuro-Oncology. 15(8). 1079–1087. 177 indexed citations

Taylor, Pete, Jason Fangusaro, Veena Rajaram, et al.. (2012). REST Is a Novel Prognostic Factor and Therapeutic Target for Medulloblastoma. Molecular Cancer Therapeutics. 11(8). 1713–1723. 40 indexed citations

10.

Riedemann, Lars, Claudia Lanvers, Dirk Deuster, et al.. (2007). Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. The Pharmacogenomics Journal. 8(1). 23–28. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact